Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR lossHuayang Liu, E. Robert McDonald, Julie Chen et al.|Nature Medicine|2018Cited by 369
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancerElena Élez, Rodrigo A. Toledo, Javier Ros et al.|Nature Medicine|2022Cited by 111